Loading companies…
Germany · Biotech
A phage-discovery and development company that uses bacteriophage libraries, bioinformatics and machine learning to identify targeted solutions against bacterial strains.
PhageStack combines a bacteriophage collection with computational analysis to find phages that act against a customer’s target bacteria. Its service analyzes bacterial genetics and bacteria–phage interactions to select candidate phages for development. The company describes applications across medical, agricultural, industrial and environmental settings; its core capability is enabling phage-based alternatives for problems involving bacteria, including antimicrobial resistance.
PhageStack serves organizations developing phage-based solutions. A customer supplies or identifies a bacterial target; the company uses its phage bank and bioinformatics to identify suitable candidates and support downstream solution development. Founded in 2023, it is an early-stage biotech company based in Pulheim, Germany.
| Announced | Round | Amount | Investors |
|---|---|---|---|
| NRW.BANK investment | Undisclosed | NRW.BANK — Participant |